Abstract #2189
Longitudinal quantitative MRI Provides Quality Assurance Measures in Patients with Ischemic Stroke Treated with Autologous Bone Marrow Derived Mononuclear Cells.
Muhammad E Haque 1 , Khader M Hasan 2 , Benjamin A Schatz 3 , Sarah M Lund 3 , Farhaan S Vahidy 4 , and Sean I Savitz 4
1
Neurology, Unversity of Texas Health Science
Center at Houston, Houston, TX, United States,
2
Diagnostic
and Interventional Imaging, Unversity of Texas Health
Science Center at Houston, Houston, TX, United States,
3
Unversity
of Texas Health Science Center at Houston, TX, United
States,
4
Neurology,
Unversity of Texas Health Science Center at Houston, TX,
United States
Post stroke cell therapy may offer a promising
regenerative therapy. There is a need to establish
reliable neuroimaging markers to assure safety and help
advance neubiological models. In this study we sought to
present some quality assurance measures by testing the
integrity of white matter fibers in the anterior and
posterior corpus callosum regions post MCA stroke.
This abstract and the presentation materials are available to members only;
a login is required.
Join Here
